Clinical Trial Update: A Survey to Evaluate the Rate of Abnormal Glucose Tolerance Among Hong Kong Chinese Subjects With Coronary Heart Disease

View source ↗

Summary

This clinical trial investigating abnormal glucose tolerance in Hong Kong Chinese patients with coronary heart disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Diabetes Mellitus

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Coronary Heart Disease, Diabetes Mellitus | Status: WITHDRAWN